Kefiran suppresses antigen-induced mast cell activation

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 2, 2012, Pages 178-183

  Furuno, Tadahide ^a   Nakanishi, Mamoru ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Ca 2+ mobilization; Cytokine; Degranulation; Kefiran; Mast cell; Phosphorylation

Indexed keywords

ANTIGEN; CALCIUM ION; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BEVERAGE; BONE MARROW CELL; CALCIUM MOBILIZATION; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; KEFIRAN; MAST CELL; MAST CELL DEGRANULATION; MILK; MOUSE; NONHUMAN;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BONE MARROW CELLS; CALCIUM; CELL DEGRANULATION; CELLS, CULTURED; CHROMONES; ENZYME INHIBITORS; MAST CELLS; MICE; MICE, INBRED BALB C; MORPHOLINES; PHOSPHOTRANSFERASES; POLYSACCHARIDES; RECEPTORS, IGE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84856585846     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.35.178     Document Type: Article

References (29)

1. Ismaiel AA, Ghaly MF, El-Naggar AK. Milk kefir: ultrastructure, antimicrobial activity and efficacy on aflatoxin B1 production by Aspergillus flavus. Curr. Microbiol., 62, 1602-1609 (2011).
2. Lopitz-Otsoa F, Rementeria A, Elguezabal N, Garaizar J. Kefir: a symbiotic yeasts-bacteria community with alleged healthy capabilities. Rev. Iberoam. Micol., 23, 67-74 (2006).
3. Kooiman P. The chemical structure of kefiran, the water-soluble polysaccharide of the kefir grain. Carbohydr. Res., 7, 200-211 (1968).
4. T. J. Agric. Food Chem., 52, 5533-5538 (2004).
5. Yokoi H, Watanabe T, Fuji Y, Toba T, Adachi S. Isolation and characterization of polysaccharide-producing bacteria from kefir grains. J. Dairy Sci., 73, 1684-1689 (1990).
6. Cheirsilp B, Shoji H, Shimizu H, Shioya S. Interactions between Lactobacillus kefiranofaciens and Saccharomyces cerevisiae in mixed culture for kefiran production. J. Biosci. Bioeng., 96, 279-284 (2003).
7. Maeda H, Zhu X, Mitsuoka T. New medium for the production of exopolysaccharide (OSKC) by Lactobacillus kefiranofaciens. Bioscience Microflora, 22, 45-50 (2003).
8. Maeda H, Zhu X, Omura K, Suzuki S, Kitamura S. Effects of an exopolysaccharide (kefiran) on lipids, blood pressure, blood glucose, and constipation. Biofactors, 22, 197-200 (2004).
9. Uchida M, Ishii I, Inoue C, Akisato Y, Watanabe K, Hosoyama S, Toida T, Ariyoshi N, Kitada M. Kefiran reduces atherosclerosis in rabbits fed a high cholesterol diet. J. Atheroscler. Thromb., 17, 980-988 (2010).
10. Maeda H, Mizumoto H, Suzuki M, Tsuji K. Effects of kefiran-feeding on fecal cholesterol excretion, hepatic injury and intestinal histamine concentration in rats. Bioscience Microflora, 24, 35-40 (2005).
11. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, Cohen P. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol., 7, 261-269 (1997).
12. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CMM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol., 23, 749-786 (2005).
13. Rivera J. Molecular adapters in FcεRI signaling and the allergic response. Curr. Opin. Immunol., 14, 688-693 (2002).
14. Abramson J, Pecht I. Regulation of the mast cell response to the type 1 Fc ε receptor. Immunol. Rev., 217, 231-254 (2007).
15. Hoshino Y, Hirashima N, Nakanishi M, Furuno T. Inhibition of degranulation and cytokine production in bone marrow-derived mast cells by hydrolyzed rice bran. Inflamm. Res., 59, 615-625 (2010).
16. Teshima R, Suzuki K, Ikebuchi H, Terao T. Possible involvement of phosphorylation of a 36,000-dalton protein of rat basophilic leukemia (RBL-2H3) cell membranes in serotonin release. Mol. Immunol., 23, 279-284 (1986).
17. Nakamura R, Furuno T, Nakanishi M. The plasma membrane shuttling of CAPRI is related to regulation of mast cell activation. Biochem. Biophys. Res. Commun., 347, 363-368 (2006).
18. Chikamatsu S, Furuno T, Kinoshita Y, Inoh Y, Hirashima N, Teshima R, Nakanishi M. Effects of Cot expression on the nuclear translocation of NF-κB in RBL-2H3 cells. Mol. Immunol., 44, 1490-1497 (2007).
19. Furuno T, Hirashima N, Onizawa S, Sagiya N, Nakanishi M. Nuclear shuttling of mitogen-activated protein (MAP) kinase (extracellular signal-regulated kinase (ERK) 2) was dynamically controlled by MAP/ERK kinase after antigen stimulation in RBL-2H3 cells. J. Immunol., 166, 4416-4421 (2001).
20. Kitaura J, Asai K, Maeda-Yamamoto M, Kawakami Y, Kikkawa U, Kawakami T. Akt-dependent cytokine production in mast cells. J. Exp. Med., 192, 729-740 (2000).
21. Zhang C, Baumgartner RA, Yamada K, Beaven MA. Mitogen-activated protein (MAP) kinase regulates production of tumor necrosis factor-α and release of arachidonic acid in mast cells. Indications of communication between p38 and p42 MAP kinases. J. Biol. Chem., 272, 13397-13402 (1997).
22. Kim MS, Rådinger M, Gilfillan AM. The multiple roles of phosphoinositide 3-kinase in mast cell biology. Trends Immunol., 29, 493-501 (2008).
23. Rådinger M, Kuehn HS, Kim MS, Metcalfe DD, Gilfillan AM. Glycogen synthase kinase 3β activation is a prerequisite signal for cytokine production and chemotaxis in human mast cells. J. Immunol., 184, 564-572 (2010).
24. Ishizuka T, Chayama K, Takeda K, Hamelmann E, Terada N, Keller GM, Johnson GL, Gelfand EW. Mitogen-activated protein kinase activation through Fc ε receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells. J. Immunol., 162, 2087-2094 (1999).
25. 2+entry mechanism. J. Biol. Chem., 276, 14814-14820 (2001).
26. Medrano M, Racedo SM, Rolny IS, Abraham AG, Pérez PF. Oral administration of kefiran induces changes in the balance of immune cells in a murine model. J. Agric. Food Chem., 59, 5299-5304 (2011).
27. Rodrigues KL, Carvalho JC, Schneedorf JM. Anti-inflammatory properties of kefir and its polysaccharide extract. Inflammopharmacology, 13, 485-492 (2005).
28. Vinderola G, Perdigón G, Duarte J, Farnworth E, Matar C. Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity. Cytokine, 36, 254-260 (2006).
29. Kwon OK, Ahn KS, Lee MY, Kim SY, Park BY, Kim MK, Lee IY, Oh SR, Lee HK. Inhibitory effect of kefiran on ovalbumin-induced lung inflammation in a murine model of asthma. Arch. Pharm. Res., 31, 1590-1596 (2008).